<DOC>
	<DOCNO>NCT00168038</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , tolerability safety IgPro10 treatment patient chronic immune thrombocytopenic purpura ( ITP ) . The main efficacy parameter proportion patient respond treatment increase platelet count ≥ 50 x 10^9/L .</brief_summary>
	<brief_title>Treatment Chronic Immune Thrombocytopenic Purpura ( ITP ) With Intravenous Immunoglobulin IgPro10</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Key Diagnosis chronic ITP define : Failure find cause thrombocytopenia ; Platelet count ≤ 150 x 10^9/L 6 month response previous treatment subsequent decrease platelet count even duration chronic ITP le 6 month Platelet count ≤ 20 x 10^9/L Key Planned splenectomy throughout study period Treatment IVIG antiD immunoglobulin within 3 week prior screen Treatment immunosuppressive immunomodulatory drug within 3 week prior screen Treatment intravenous steroid within 10 day prior screen Change oral steroid treatment within 15 day prior screen Patients know suspected hypersensitivity immunoglobulins previous severe side effect immunoglobulin therapy Abnormal result follow laboratory parameter : Hemoglobin &lt; 10 g/dL ; Total bilirubin &gt; 1.5 x upper normal limit ; ALAT &gt; 2.5 x upper normal limit ; ASAT &gt; 2.5 x upper normal limit ; Creatinine &gt; 1.5 x upper normal limit ; Urea &gt; 1.5 x upper normal limit Positive direct Coombs test Patients one follow concomitant disease Clinical active SLE Known suspect HIV infection Acute hepatitis Clinically active chronic hepatitis Lymphoproliferative disease Heart failure Grade III IV accord New York Heart Association classification Any concomitant disease influence clot system ( i.e . hemophilia )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Chronic Immune Thrombocytopenic Purpura</keyword>
	<keyword>Chronic Idiopathic Thrombocytopenic Purpura</keyword>
	<keyword>Werlhofs Disease</keyword>
	<keyword>Autoimmune Thrombocytopenia</keyword>
	<keyword>Immunglobulin Intravenous</keyword>
	<keyword>Chronic ITP</keyword>
	<keyword>Platelet count</keyword>
	<keyword>Thrombocytopenia</keyword>
</DOC>